Madhucon Projects Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 5:07 pm

Quick Insight

Madhucon Projects Ltd, operating in the construction sector, presents a concerning financial profile, with a current share price of ₹6.71 and a market capitalization of ₹49.5 crore. The company’s negative net profit of ₹523 crore and reserves of ₹-1,475 crore suggest significant financial distress. With a P/BV of just 0.04x, the stock appears undervalued, yet this may reflect underlying issues, including a high borrowing level of ₹3,554 crore and an ICR of only 0.05x, indicating the inability to cover interest obligations. Furthermore, the company's CCC of -130 days raises liquidity concerns. Given these metrics, potential investors should exercise caution, as the combination of poor profitability and high leverage poses substantial risk.

Competitors of Madhucon Projects Ltd

All Competitor Stocks of Madhucon Projects Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:33 am

Below is a detailed analysis of the quarterly data for Madhucon Projects Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 139.00 Cr.. The value appears strong and on an upward trend. It has increased from 111.00 Cr. (Dec 2024) to 139.00 Cr., marking an increase of 28.00 Cr..
• For Expenses, as of Mar 2025, the value is 175.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 137.00 Cr. (Dec 2024) to 175.00 Cr., marking an increase of 38.00 Cr..
• For Operating Profit, as of Mar 2025, the value is -36.00 Cr.. The value appears to be declining and may need further review. It has decreased from -26.00 Cr. (Dec 2024) to -36.00 Cr., marking a decrease of 10.00 Cr..
• For OPM %, as of Mar 2025, the value is -26.00%. The value appears to be declining and may need further review. It has decreased from -23.00% (Dec 2024) to -26.00%, marking a decrease of 3.00%.
• For Other Income, as of Mar 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Dec 2024) to 37.00 Cr., marking a decrease of 30.00 Cr..
• For Interest, as of Mar 2025, the value is 27.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Dec 2024) to 27.00 Cr., marking an increase of 22.00 Cr..
• For Depreciation, as of Mar 2025, the value is 26.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 484.00 Cr. (Dec 2024) to 26.00 Cr., marking a decrease of 458.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -52.00 Cr.. The value appears strong and on an upward trend. It has increased from -447.00 Cr. (Dec 2024) to -52.00 Cr., marking an increase of 395.00 Cr..
• For Tax %, as of Mar 2025, the value is 18.00%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Dec 2024) to 18.00%, marking an increase of 18.00%.
• For Net Profit, as of Mar 2025, the value is -61.00 Cr.. The value appears strong and on an upward trend. It has increased from -446.00 Cr. (Dec 2024) to -61.00 Cr., marking an increase of 385.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -5.27. The value appears strong and on an upward trend. It has increased from -57.22 (Dec 2024) to -5.27, marking an increase of 51.95.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:53 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:46 am

Below is a detailed analysis of the balance sheet data for Madhucon Projects Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
• For Reserves, as of Mar 2025, the value is -1,475.00 Cr.. The value appears to be improving (becoming less negative). It has improved from -1,510.00 Cr. (Mar 2024) to -1,475.00 Cr., marking an improvement of 35.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3,554.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 3,913.00 Cr. (Mar 2024) to 3,554.00 Cr., marking a decrease of 359.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,526.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,802.00 Cr. (Mar 2024) to 1,526.00 Cr., marking a decrease of 276.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,612.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,213.00 Cr. (Mar 2024) to 3,612.00 Cr., marking a decrease of 601.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2024) to 124.00 Cr., marking a decrease of 45.00 Cr..
• For CWIP, as of Mar 2025, the value is 87.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 87.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,400.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,956.00 Cr. (Mar 2024) to 3,400.00 Cr., marking a decrease of 556.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,612.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,213.00 Cr. (Mar 2024) to 3,612.00 Cr., marking a decrease of 601.00 Cr..

However, the Borrowings (3,554.00 Cr.) are higher than the Reserves (-1,475.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Madhucon Projects Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is -6.11. This value is below the healthy minimum of 5. It has increased from -19.47 (Mar 23) to -6.11, marking an increase of 13.36.
• For Diluted EPS (Rs.), as of Mar 24, the value is -6.11. This value is below the healthy minimum of 5. It has increased from -19.47 (Mar 23) to -6.11, marking an increase of 13.36.
• For Cash EPS (Rs.), as of Mar 24, the value is -3.91. This value is below the healthy minimum of 3. It has decreased from 83.99 (Mar 23) to -3.91, marking a decrease of 87.90.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -268.52. It has increased from -318.40 (Mar 23) to -268.52, marking an increase of 49.88.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -268.52. It has increased from -318.40 (Mar 23) to -268.52, marking an increase of 49.88.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 157.20. It has increased from 157.00 (Mar 23) to 157.20, marking an increase of 0.20.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 0.32. This value is below the healthy minimum of 2. It has decreased from 87.65 (Mar 23) to 0.32, marking a decrease of 87.33.
• For PBIT / Share (Rs.), as of Mar 24, the value is -3.98. This value is below the healthy minimum of 0. It has increased from -20.26 (Mar 23) to -3.98, marking an increase of 16.28.
• For PBT / Share (Rs.), as of Mar 24, the value is -9.57. This value is below the healthy minimum of 0. It has increased from -26.63 (Mar 23) to -9.57, marking an increase of 17.06.
• For Net Profit / Share (Rs.), as of Mar 24, the value is -8.21. This value is below the healthy minimum of 2. It has increased from -23.93 (Mar 23) to -8.21, marking an increase of 15.72.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -6.09. This value is below the healthy minimum of 2. It has increased from -19.41 (Mar 23) to -6.09, marking an increase of 13.32.
• For PBDIT Margin (%), as of Mar 24, the value is 0.20. This value is below the healthy minimum of 10. It has decreased from 55.83 (Mar 23) to 0.20, marking a decrease of 55.63.
• For PBIT Margin (%), as of Mar 24, the value is -2.52. This value is below the healthy minimum of 10. It has increased from -12.90 (Mar 23) to -2.52, marking an increase of 10.38.
• For PBT Margin (%), as of Mar 24, the value is -6.08. This value is below the healthy minimum of 10. It has increased from -16.96 (Mar 23) to -6.08, marking an increase of 10.88.
• For Net Profit Margin (%), as of Mar 24, the value is -5.22. This value is below the healthy minimum of 5. It has increased from -15.24 (Mar 23) to -5.22, marking an increase of 10.02.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is -3.87. This value is below the healthy minimum of 8. It has increased from -12.36 (Mar 23) to -3.87, marking an increase of 8.49.
• For Return on Capital Employeed (%), as of Mar 24, the value is 113.58. This value is within the healthy range. It has increased from 35.91 (Mar 23) to 113.58, marking an increase of 77.67.
• For Return On Assets (%), as of Mar 24, the value is -1.07. This value is below the healthy minimum of 5. It has increased from -3.49 (Mar 23) to -1.07, marking an increase of 2.42.
• For Long Term Debt / Equity (X), as of Mar 24, the value is -1.05. This value is below the healthy minimum of 0.2. It has decreased from -0.86 (Mar 23) to -1.05, marking a decrease of 0.19.
• For Total Debt / Equity (X), as of Mar 24, the value is -2.54. This value is within the healthy range. It has decreased from -1.68 (Mar 23) to -2.54, marking a decrease of 0.86.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.00. It has decreased from 0.24 (Mar 23) to 0.00, marking a decrease of 0.24.
• For Current Ratio (X), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 1.5. It has decreased from 0.54 (Mar 23) to 0.53, marking a decrease of 0.01.
• For Quick Ratio (X), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 1. It has decreased from 0.54 (Mar 23) to 0.53, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 222.50 (Mar 23) to 0.00, marking a decrease of 222.50.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 3. It has decreased from 13.77 (Mar 23) to 0.05, marking a decrease of 13.72.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -0.46. This value is below the healthy minimum of 3. It has increased from -2.76 (Mar 23) to -0.46, marking an increase of 2.30.
• For Enterprise Value (Cr.), as of Mar 24, the value is 3,357.31. It has increased from 2,724.44 (Mar 23) to 3,357.31, marking an increase of 632.87.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.88. This value is within the healthy range. It has increased from 2.34 (Mar 23) to 2.88, marking an increase of 0.54.
• For EV / EBITDA (X), as of Mar 24, the value is 1,412.95. This value exceeds the healthy maximum of 15. It has increased from 4.20 (Mar 23) to 1,412.95, marking an increase of 1,408.75.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 23) to 0.05, marking an increase of 0.03.
• For Price / BV (X), as of Mar 24, the value is -0.04. This value is below the healthy minimum of 1. It has decreased from -0.01 (Mar 23) to -0.04, marking a decrease of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 23) to 0.05, marking an increase of 0.03.
• For EarningsYield, as of Mar 24, the value is -0.66. This value is below the healthy minimum of 5. It has increased from -5.63 (Mar 23) to -0.66, marking an increase of 4.97.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness